-+ 0.00%
-+ 0.00%
-+ 0.00%

Evofem Biosciences Implements 1-for-1,500 Reverse Stock Split

PUBT·11/18/2026 21:59:27
Listen to the news
Evofem Biosciences Implements 1-for-1,500 Reverse Stock Split
  • Evofem Biosciences is implementing a 1-for-1,500 reverse stock split effective November 18, 2026.
  • Outstanding common shares will fall from approximately 132,530,081 as of November 17, 2026, to approximately 88,353.
  • The consolidation aims to ensure sufficient authorized common shares to cover shares underlying financial instruments on a fully diluted basis.
  • Split-adjusted trading begins on the OTC Basic Market under EVFMD, with the ticker reverting to EVFM after 20 business days.
  • No fractional shares will be issued; holders will receive cash instead, based on the November 17, 2026, closing price.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Evofem Biosciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-053094), on November 18, 2026, and is solely responsible for the information contained therein.